FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH

MANHASSET, NY

OncologyPhase II

What changed

Study registered, no phase assigned: Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls

4d agoTrial registeredJul 16, 2026Source filing (opens the source filing in a new tab)

Momentum

98no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,843 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R01 · $769k · non-dilutive
Mar 1, 2026
MASSACHUSETTS GENERAL HOSPITAL · PI LAZARO-MUNOZ, GABRIEL · NIDA · award ends Dec 31, 2029 · Genomic Tests for Substance Use Disorders in Clinical Care: Examining Challenges and Opportunities
NIH RePORTER · NIH RePORTER 11309743 (opens the source filing in a new tab)
Trial
NA registered
May 15, 2025
Hypoxic Ischemic Encephalopathy of Newborn, Hypoxic Ischemic Encephalopathy, Hypoxic Ischemic Encephalopathy (HIE) · RECRUITING · sponsor: Baylor College of Medicine · The HIEnome Study: Genome Sequencing for Perinatal HIE
ClinicalTrials.gov · NCT06762795 (opens the source filing in a new tab)
Grant
R01 · $706k · non-dilutive
Sep 25, 2024
BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN · NHGRI · award ends Jul 31, 2029 · MAGNET: MAKING GENOMICS ACCESSIBLE FOR NEWBORNS IN TEXAS
NIH RePORTER · NIH RePORTER 11197613 (opens the source filing in a new tab)
Trial
NA registered
Aug 1, 2022
Osteogenesis Imperfecta · ACTIVE_NOT_RECRUITING · sponsor: Baylor College of Medicine · Clear Aligners for the Treatment of Dental Malocclusion in OI
ClinicalTrials.gov · NCT04815564 (opens the source filing in a new tab)
Trial
Study registered
Aug 1, 2022
Osteogenesis Imperfecta · ACTIVE_NOT_RECRUITING · sponsor: Baylor College of Medicine · Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708
ClinicalTrials.gov · NCT05317637 (opens the source filing in a new tab)
Grant
R01 · $662k · non-dilutive
Jul 13, 2022
BAYLOR COLLEGE OF MEDICINE · PI PARK, DONGSU · NIDCR · award ends Apr 30, 2027 · Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
NIH RePORTER · NIH RePORTER 11313819 (opens the source filing in a new tab)
Trial
NA registered
Jun 1, 2022
Birth Defects, Multiple Congenital Anomaly, Neurodevelopmental Disorders · RECRUITING · sponsor: Baylor College of Medicine · Genetic Inclusion by Virtual Evaluation
ClinicalTrials.gov · NCT05318222 (opens the source filing in a new tab)
Trial
PHASE1/PHASE2 registered
May 13, 2022
Hypermobile Ehlers-Danlos Syndrome, Pain Assessment · TERMINATED · sponsor: Baylor College of Medicine · Oxytocin for Hypermobile Ehlers-Danlos Syndrome
ClinicalTrials.gov · NCT05405257 (opens the source filing in a new tab)
Grant
UH3 · $465k · non-dilutive
Feb 1, 2022
BAYLOR COLLEGE OF MEDICINE · PI LALANI, SEEMA R · NCATS · award ends Jan 31, 2027 · Expanding Access to Genetic Evaluation Through Virtual Platforms
NIH RePORTER · NIH RePORTER 11362021 (opens the source filing in a new tab)
Grant
R01 · $3.3M · non-dilutive
Jun 1, 2021
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI LENCZ, TODD · NHGRI · award ends Aug 31, 2029 · Polygenic Embryo Screening: Towards Informed Decision-Making
NIH RePORTER · NIH RePORTER 11159169 (opens the source filing in a new tab)
Trial
Study registered
Nov 15, 2018
Graft Versus Host Disease · COMPLETED · sponsor: National Institute of Dental and Craniofacial Research (NIDCR) · Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
ClinicalTrials.gov · NCT03602599 (opens the source filing in a new tab)
Trial
Study registered
May 18, 2018
TANGO2-related Disorder · RECRUITING · sponsor: Baylor College of Medicine · Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder
ClinicalTrials.gov · NCT05374616 (opens the source filing in a new tab)
Trial
Study registered
Aug 1, 2016
Osteogenesis Imperfecta · ACTIVE_NOT_RECRUITING · sponsor: Baylor College of Medicine · Dental Malocclusion and Craniofacial Development in OI
ClinicalTrials.gov · NCT02934451 (opens the source filing in a new tab)
Trial
Study registered
Jun 1, 2015
Osteogenesis Imperfecta · RECRUITING · sponsor: Baylor College of Medicine · BBD Longitudinal Study of Osteogenesis Imperfecta
ClinicalTrials.gov · NCT02432625 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 75%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
4d agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
4d agoTrial completedSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
3mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708
4mo agoTrial registeredSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Genomic Tests for Substance Use Disorders in Clinical Care: Examining Challenges and Opportunities
4mo agoNew grantSource (opens the source filing in a new tab)
NIH UH3 · $0.5M · Expanding Access to Genetic Evaluation Through Virtual Platforms
4mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Dental Malocclusion and Craniofacial Development in OI
5mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Clear Aligners for the Treatment of Dental Malocclusion in OI
7mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder
9mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder
9mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: The HIEnome Study: Genome Sequencing for Perinatal HIE
9mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: The HIEnome Study: Genome Sequencing for Perinatal HIE
9mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH R01 · $0.7M · MAGNET: MAKING GENOMICS ACCESSIBLE FOR NEWBORNS IN TEXAS
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $3.3M · Polygenic Embryo Screening: Towards Informed Decision-Making
10mo agoGrant renewalSource (opens the source filing in a new tab)
Phase II trial registered: Oxytocin for Hypermobile Ehlers-Danlos Syndrome
10mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: BBD Longitudinal Study of Osteogenesis Imperfecta
11mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: BBD Longitudinal Study of Osteogenesis Imperfecta
11mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Genetic Inclusion by Virtual Evaluation
Jan 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Genetic Inclusion by Virtual Evaluation
Jan 2025Trial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

R01 · $769k · non-dilutive

NA registered

R01 · $706k · non-dilutive

NA registered

Study registered

R01 · $662k · non-dilutive

NA registered

PHASE1/PHASE2 registered

UH3 · $465k · non-dilutive

R01 · $3.3M · non-dilutive

Study registered

Study registered

Study registered

Study registered